| 1 |
systemic sclerosis
(5913 times)
|
Rheumatology
(2921 times)
|
SLE (424 times)
ILD (333 times)
PAH (320 times)
|
1986 Alpha 1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis.
|
| 2 |
systemic scleroderma
(70 times)
|
Dermatology
(17 times)
|
SLE (10 times)
DM (6 times)
RA (6 times)
|
1990 Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
|
| 3 |
Systemic sclerosis or scleroderma
(7 times)
|
Rheumatology
(3 times)
|
ACE (1 time)
FLI1 (1 time)
ICAM-1 (1 time)
|
2003 Implication of intercellular adhesion molecule-1 (ICAM-1) and serum N(G)-hydroxy-L-arginine (L-NHA) in the pathogenesis of systemic sclerosis.
|
| 4 |
sclerosis, scleroderma
(4 times)
|
Rheumatology
(4 times)
|
alpha-MSH (1 time)
ANA (1 time)
AS (1 time)
|
2005 Classification of systemic sclerosis. Visions and reality.
|
| 5 |
systemic sclerosis patients
(4 times)
|
Medicine
(2 times)
|
BALF (1 time)
Col I, III, and V (1 time)
DS (1 time)
|
2004 BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
|
| 6 |
saikosaponin C
(3 times)
|
Neurology
(1 time)
|
AD (1 time)
FAK (1 time)
LPS (1 time)
|
2014 Saikosaponin C inhibits lipopolysaccharide-induced apoptosis by suppressing caspase-3 activation and subsequent degradation of focal adhesion kinase in human umbilical vein endothelial cells.
|
| 7 |
sclerosis
(3 times)
|
Rheumatology
(3 times)
|
ACA (1 time)
CI (1 time)
ECM (1 time)
|
2007 Anticentromere antibodies identify patients with Sjogren's syndrome and autoimmune overlap syndrome.
|
| 8 |
secondary spermatocyte
(2 times)
|
Cell Biology
(2 times)
|
AT (1 time)
ESt (1 time)
LSt (1 time)
|
2008 Spermatogenesis and chromatin condensation in male germ cells of sea cucumber Holothuria leucospilota (Clark, 1920).
|
| 9 |
systemic autoimmune diseases, including scleroderma
(2 times)
|
Immunity
(1 time)
|
GN (1 time)
RA (1 time)
SLE (1 time)
|
1999 Microchimerism and scleroderma.
|
| 10 |
systemic sclerosis-associated pulmonary fibrosis
(2 times)
|
Pulmonary Medicine
(1 time)
|
IPF (2 times)
CI (1 time)
EBV (1 time)
|
2000 Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis.
|
| 11 |
positive-systemic sclerosis
(1 time)
|
Rheumatology
(1 time)
|
ACA (1 time)
pSS (1 time)
sSS (1 time)
|
2013 Overlap of ACA-positive systemic sclerosis and Sjogren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
|
| 12 |
same sclerodermic
(1 time)
|
Immune System Diseases
(1 time)
|
AECA (1 time)
alpha-SMA (1 time)
CTR (1 time)
|
2015 From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
|
| 13 |
Sardinian schoolchildren
(1 time)
|
Endocrinology
(1 time)
|
GADA (1 time)
HR (1 time)
ICA (1 time)
|
2016 Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study.
|
| 14 |
scleroderma patients
(1 time)
|
Allergy and Immunology
(1 time)
|
beta-Gal (1 time)
HC (1 time)
IL (1 time)
|
2013 Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
|
| 15 |
scleroderma/sclerosis
(1 time)
|
Gastroenterology
(1 time)
|
BMI (1 time)
CI (1 time)
FSS (1 time)
|
2019 The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality.
|
| 16 |
sclerosis spectrum disorders
(1 time)
|
Vascular Diseases
(1 time)
|
NCM (1 time)
|
1992 Evaluation of the severity of systemic sclerosis by nailfold capillary microscopy in 112 patients.
|
| 17 |
sclerosis subjects
(1 time)
|
Biomedical Engineering
(1 time)
|
HCs (1 time)
RP (1 time)
|
2009 Finger thermoregulatory model assessing functional impairment in Raynaud's phenomenon.
|
| 18 |
Secondary Scleroderma
(1 time)
|
Immune System Diseases
(1 time)
|
IRFI (1 time)
|
2002 Raynaud's phenomenon: Infrared functional imaging applied to diagnosis and drug effects.
|
| 19 |
significant cause of morbidity and mortality in patients with scleroderma
(1 time)
|
Rheumatology
(1 time)
|
HRCT (1 time)
|
1999 Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma.
|
| 20 |
skin sclerosis
(1 time)
|
Dermatology
(1 time)
|
FVC (1 time)
HSCT (1 time)
mRSS (1 time)
|
2018 Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
|
| 21 |
societal costs of scleroderma
(1 time)
|
Rheumatology
(1 time)
|
---
|
1997 Cost-of-illness of scleroderma: the case for rare diseases.
|
| 22 |
specific surface area
(1 time)
|
Biochemistry
(1 time)
|
BN (1 time)
NCR (1 time)
PN (1 time)
|
2016 [FUNCTIONAL MORPHOLOGY OF BLOOD ERYTHROID CELLS IN NEOGOBIUS MELANOSTOMUS P. DURING CELL DIFFERENTIATION].
|
| 23 |
SSc patients without pulmonary involvement
(1 time)
|
Rheumatology
(1 time)
|
ILD (1 time)
PAH (1 time)
SSc-ILD (1 time)
|
2015 Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
|
| 24 |
SSc without PHT
(1 time)
|
Pulmonary Medicine
(1 time)
|
PHT (1 time)
SI (1 time)
SSc-PHT (1 time)
|
1998 Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.
|
| 25 |
states common in scleroderma
(1 time)
|
Health Services Research
(1 time)
|
RS (1 time)
SG (1 time)
TTO (1 time)
|
2009 A randomized study of scleroderma health state values: a picture is worth a thousand words, and quite a few utiles. [corrected].
|
| 26 |
steady-state plasma concentration
(1 time)
|
Communicable Diseases
(1 time)
|
MIC (1 time)
|
2011 [Monitoring vancomycin in an intensive care unit: A retrospective survey on 66 patients].
|
| 27 |
subscapular
(1 time)
|
Neoplasms
(1 time)
|
AP (1 time)
BC (1 time)
SLN (1 time)
|
2015 [Use of SPECT-CT for visualization of sentinel lymph nodes in breast cancer patients].
|
| 28 |
suffering systemic
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2010 Juvenile scleroderma: experience in one institution.
|
| 29 |
sunscreen cream
(1 time)
|
Skin Diseases
(1 time)
|
MN (1 time)
NB-UVB (1 time)
UV (1 time)
|
2018 Dermoscopic changes in melanocytic nevi covered with both opaque tape and sunscreen cream during narrowband ultraviolet B therapy.
|
| 30 |
superscattering
(1 time)
|
Biophysics
(1 time)
|
CHMMs (1 time)
NSCS (1 time)
WGM (1 time)
|
2020 Superscattering from cylindrical hyperbolic metamaterials in the visible region.
|
| 31 |
suspected of being associated with scleroderma
(1 time)
|
Rheumatology
(1 time)
|
OR (1 time)
|
2004 Systemic sclerosis and occupational risk factors: role of solvents and cleaning products.
|
| 32 |
Symptom scores
(1 time)
|
Critical Care
(1 time)
|
BHR (1 time)
BUD (1 time)
CACh (1 time)
|
2000 The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children.
|
| 33 |
systemic
(1 time)
|
Dermatology
(1 time)
|
ICAM-1 (1 time)
LE (1 time)
MNC (1 time)
|
1991 Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma.
|
| 34 |
systemic bleomycin delivery that closely models scleroderma
(1 time)
|
Pharmacology
(1 time)
|
CSD (1 time)
|
2014 Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis.
|
| 35 |
systemic forms of scleroderma
(1 time)
|
Allergy and Immunology
(1 time)
|
Th (1 time)
|
2016 Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.
|
| 36 |
systemic sclerosis lung disease
(1 time)
|
Critical Care
(1 time)
|
AM (1 time)
BAL (1 time)
ET-1 (1 time)
|
1997 Endothelin-1 secretion by alveolar macrophages in systemic sclerosis.
|
| 37 |
systemic sclerosis without pulmonary hypertension
(1 time)
|
Medicine
(1 time)
|
IPAH (1 time)
PBMCs (1 time)
SSc-PAH (1 time)
|
2012 Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients.
|
| 38 |
systemic sclerosis-associated
(1 time)
|
Respiratory Tract Diseases
(1 time)
|
CI (1 time)
DLCO (1 time)
FVC (1 time)
|
2018 Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression.
|
A Search Service for Abbreviation / Long Form